Market Research Report
Peripheral Vascular Devices Market Report Suite | Global | 2020-2026 | MedSuite
|Published by||iData Research Inc.||Product code||953939|
|Published||Content info||845 Pages
Delivery time: 1-2 business days
|Peripheral Vascular Devices Market Report Suite | Global | 2020-2026 | MedSuite|
|Published: July 22, 2020||Content info: 845 Pages||
The global peripheral vascular device market was valued at $11.9 billion in 2019. This is expected to increase over the forecast period at a CAGR of 5.2% to reach $16.9 billion.
In 2020, the global peripheral vascular market will be defined by the final outcomes of the guidelines made by the National Institute of Health and Care Excellence (NICE) in the United Kingdom. This organization released original draft guidelines in 2018 suggesting that endovascular aneurysm repair (EVAR) not be performed on pre-ruptured aneurysms. The largest market, stent grafts, is expected to be significantly impacted by the globally recognized health body's final guidelines, and the decades-long trend towards EVAR might be reversed to open surgical repair.
The Asia Pacific and Latin American markets are characterized by rapidly expanding healthcare systems and growth in local treatment rates. These regions have been noted for their moderate to low pricing (excluding Japan) and are expected to achieve the highest overall growth in the peripheral vascular market. Within all regions, the venous treatment market has been growing explosively, and separate analyses estimate that the market will represent approximately 25%-33% of the bare metal stent market value by the end of 2026. This massive increase in global procedures is also increasing the total introducer sheath, guidewire, and catheter markets.
The full report suite on the global market for peripheral vascular devices includes peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy disposables, chronic total occlusion (CTO) devices, stent grafts, surgical grafts, diagnostic and interventional guidewires, diagnostic and interventional catheters, introducer sheaths, vascular closure devices (VCDs) and peripheral IVUS catheters. An analysis on intravascular lithotripsy balloon catheters is included as an appendix. Many of these devices can be used for treating either coronary arterial disease or peripheral arterial disease (PAD). However, only devices used for peripheral procedures are included in this report.